A survey and systematic assessment of computational methods for drug response prediction

Author:

Chen Jinyu,Zhang Louxin

Abstract

AbstractDrug response prediction arises from both basic and clinical research of personalized therapy, as well as drug discovery for cancers. With gene expression profiles and other omics data being available for over 1000 cancer cell lines and tissues, different machine learning approaches have been applied to drug response prediction. These methods appear in a body of literature and have been evaluated on different datasets with only one or two accuracy metrics. We systematically assess 17 representative methods for drug response prediction, which have been developed in the past 5 years, on four large public datasets in nine metrics. This study provides insights and lessons for future research into drug response prediction.

Funder

Singapore National Research Fund

Publisher

Oxford University Press (OUP)

Subject

Molecular Biology,Information Systems

Reference50 articles.

1. Drug development in the era of precision medicine;Dugger;Nat Rev Drug Discov,2018

2. Pharmacogenetics in drug discovery and development: a translational perspective;Roses;Nat Rev Drug Discov,2008

3. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay;Alley;Cancer Res,1988

4. Drug discovery: cell lines battle cancer;Weinstein;Nature,2012

5. The NCI-60 human tumour cell line anticancer drug screen;Shoemaker;Nat Rev Cancer,2006

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3